ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1976

High and Low Widespread Pain Index Fibromyalgia Patient Groups, Same, or Different?

Sahar Kaouk1, Yaseen Kinanah2, Nilamba Jhala3, Deb Bork4, Sarah Rispinto5, Sara Davin5, William Wilke4 and Carmen E. Gota4,6, 1John Carroll University, University Heights, OH, 2Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, 3Internal Medicine, Cleveland Clinic, Cleveland, OH, 4Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, 5Neurologic Institute, Cleveland Clinic, Cleveland, OH, 6The Cleveland Clinic Rheum, The Cleveland Clinic Desk A50, Cleveland, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The ACR 2010 preliminary criteria for fibromyalgia (FM) classifies patients in high WPI group, widespread pain index (WPI) ≥7, symptom severity scale (SS) ≥5, and low WPI group, WPI 3-6, SS ≥9.

It is not clear why some FM patients have less pain. Low WPI FM have lower disability scores, lower pain and global severity than high WPI group. Are there differences in the characteristics of low WPI and high WPI FM patients with regards to depressive, anxiety symptoms, pain and global FM severity and catastrophizing scores?

Methods:

Consecutive clinically diagnosed FM patients were classified in low WPI or high WPI groups, demographic and clinical data was compared. Questionnaires used: patient health questionnaire (PHQ-9), general anxiety disorder questionnaire (GAD-7), health assessment questionnaire disability index (HAQ-DI), fibromyalgia impact questionnaire (FIQ), pain disability index, pain catastrophizing scale, polysymptomatic distress scale (PSD), as the sum of WPI and SS.

Results:

Of 552 patients diagnosed clinically with FM, age 44.3 (12), 79.5% white, 85.5% female, 4% met the low WPI and 82.1% met the high WPI criteria.

Only SS, WPI and PSD, were each significantly different between low and high WPI groups (Table 1). To understand why, we looked at the individual correlations of WPI and SS (Table 2). In linear regression model, PHQ-9, GAD-7, Pain disability index, Pain catastrophizing, HAQ-DI and FIQ significantly predict WPI, F(6,98)=4.904, P<0.0001, R2 0.184; FIQ remains an independent predictor of WPI. The same model predicts SS, F(6, 98)=17.932, P<0.0001, R2 0.523; FIQ, pain catastrophizing score, PHQ-9 remain independent predictors of SS.

Table 1. Fibromyalgia and severity measures according to criteria categories. Values are mean (SD) unless specified. Low WPI and high WPI group are statistically significant different from each other at p <0.05 if flagged with asterisks; * p<0.05; ** P<0.001

All

WPI 3-6 and SS ≥9

WPI ≥7 and SS ≥ 5

N

475

22

453

Age, yrs

43.9 (11.7)

40.9 (12.9)

44.1 (11.6)

Female, %

86.7%

90.9%

86.5%

Race white %

79.8%

81.8%

79.7%

Employed full time %

36.4%

36.4%

36.4%

WPI

12.6 (3.7)

4.6 (1.0)

12.9 (3.4)**

SS

9.3 (1.9)

10.4 (1.1)

9.2 (1.9)*

PSD

21.9 (4.5)

15 (1.4)

22.2 (4.3)**

FIQ

60.6 (19.4)

47.5 (13.7)

60.9 (7.2)

PHQ-9

13.3 (6.0)

12.4 (5.3)

13.3 (6.1)

GAD-7

9.5 (7.1)

8.8 (6.2)

9.5 (7.2)

HAQ-DI

1.2 (1.6)

1.2 (1.9)

1.2 (1.5)

Pain catastrophizing

23.9 (13.2)

20.3 (14)

24 (13.3)

Pain disability index

5.6 (2.1)

4.9 (2.4)

5.7 (2.1)

Table 2. WPI and SS correlations with pain disability index, FIQ, HAQ-DI, PHQ-9, GAD7 and PSD. Unless specified by * all correlations were significant at p<0.0001,* P<0.05

WPI

SS

PSD

0.911

0.541

SS

0.175

Pain disability index

0.301

0.421

FIQ

0.352

0.569

HAQ-DI

0.293

0.316

PHQ-9

0.271

0.516

GAD-7

0.170

0..344

Pain catastrophizing

0.205*

0.338

Conclusion:

No differences were found between high and low WPI groups, except for significantly higher PSD scores, despite many variables trending higher in the high WPI group, possibly due to the low number of patients in the low WPI group. We found that WPI and SS differ in their strength of association with core FM domains, which suggests they contribute differently to FM diagnosis.


Disclosure: S. Kaouk, None; Y. Kinanah, None; N. Jhala, None; D. Bork, None; S. Rispinto, None; S. Davin, None; W. Wilke, None; C. E. Gota, None.

To cite this abstract in AMA style:

Kaouk S, Kinanah Y, Jhala N, Bork D, Rispinto S, Davin S, Wilke W, Gota CE. High and Low Widespread Pain Index Fibromyalgia Patient Groups, Same, or Different? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/high-and-low-widespread-pain-index-fibromyalgia-patient-groups-same-or-different/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-and-low-widespread-pain-index-fibromyalgia-patient-groups-same-or-different/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology